H.J. Keizer
Impact in
-
- Sarcoma Diagnosis and Treatment
- Oncology top 5%
- Vascular Tumors and Angiosarcomas
Papers in
- Co-authors
- Ewout W. Steyerberg (15 shared papers)Dirk Th. Sleijfer (6 shared papers)Jos H. Beijnen (9 shared papers)Guy C. Toner (5 shared papers)John P. Donohue (5 shared papers)Ian Judson (3 shared papers)C. Hermans (3 shared papers)Jaap Verweij (4 shared papers)
- Journals
- European Journal of Cancer (7 papers)Annals of Oncology (5 papers)Journal of Clinical Oncology (5 papers)British Journal of Cancer (4 papers)Cancer (3 papers)
- Partner nations
- NetherlandsBelgiumUnited Kingdom
In The Last Decade
H.J. Keizer
61 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 106
- Pulmonary and Respiratory Medicine 816
- Oncology 666
- Reproductive Medicine 190
- Gastroenterology 123
- Pathology and Forensic Medicine 387
Countries citing papers authored by H.J. Keizer
This map shows the geographic impact of H.J. Keizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.J. Keizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.J. Keizer more than expected).
Fields of papers citing papers by H.J. Keizer
This network shows the impact of papers produced by H.J. Keizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.J. Keizer. The network helps show where H.J. Keizer may publish in the future.
Co-authors
The 25 scholars most cited alongside H.J. Keizer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 186 | |
| 2 | 1995 | 180 | |
| 3 | 2000 | 163 | |
| 4 | 2000 | 108 | |
| 5 | 2001 | 101 | |
| 6 | 2002 | 96 | |
| 7 | 1999 | 89 | |
| 8 | 1998 | 72 | |
| 9 | 1996 | 69 | |
| 10 | 2000 | 60 | |
| 11 | 2001 | 54 | |
| 12 | 1999 | 50 | |
| 13 | 1996 | 50 | |
| 14 | Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group. | 1997 | 49 |
| 15 | 1994 | 42 | |
| 16 | 1993 | 40 | |
| 17 | 2000 | 39 | |
| 18 | 1970 | 39 | |
| 19 | 2003 | 38 | |
| 20 | 1997 | 36 |
About H.J. Keizer
H.J. Keizer is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 61 papers that have together received 2.2k indexed citations. Recurring topics across this work include Testicular diseases and treatments (19 papers), Chemotherapy-induced organ toxicity mitigation (11 papers), Sarcoma Diagnosis and Treatment (9 papers), Ovarian cancer diagnosis and treatment (8 papers), Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Treatment and Pharmacology (4 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (816 citations), Oncology (666 citations), Reproductive Medicine (190 citations), Gastroenterology (123 citations) and Pathology and Forensic Medicine (387 citations). H.J. Keizer has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Ewout W. Steyerberg, Dirk Th. Sleijfer, Jos H. Beijnen, Guy C. Toner, John P. Donohue, Ian Judson, C. Hermans, Jaap Verweij, M. van Glabbeke and Jean‐Yves Blay. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.